
The BluePearl Greater Philadelphia network hospitals are offering a funded study evaluating the first-in-class liquid biopsy test from PetDx in 2022.

The BluePearl Greater Philadelphia network hospitals are offering a funded study evaluating the first-in-class liquid biopsy test from PetDx in 2022.


A novel immunotherapy for dogs with osteosarcoma is discussed.

Published: September 16th 2021 | Updated:

Published: January 30th 2022 | Updated: